Results 171 to 180 of about 7,495 (248)

Acute dose-dependent effects and self-guided titration of continuous N,N-dimethyltryptamine infusions in a double-blind placebo-controlled study in healthy participants. [PDF]

Neuropsychopharmacology
Erne L, Vogt SB, Müller L, Nuraj A, Becker A, Klaiber A, Zuparic M, Varghese N, Eckert A, Rudin D, Luethi D, Liechti ME.   +11 more
europepmc   +1 more source

Editorial: Beyond psilocybin: exploring the clinical potential of alternative and novel psychedelics. [PDF]

Front Psychiatry
Williams ML, Rudin D, Schmid Y, von Salm J.   +3 more
europepmc   +1 more source

Banisteriopsis caapi [PDF]

, 1998
Emmert, Susan
core   +1 more source

Targeting the 5-HT_2A Receptor for Developing Psychedelic Drugs and Beyond. [PDF]

J Med Chem
Ali S, Tian X, Cunningham KA, Zhou J.
europepmc   +1 more source

Simple Analogs of the LSD D-Ring: A Consideration of Structure-Activity Relationships and Their Potential as Therapeutics. [PDF]

ACS Chem Neurosci
Barker SA.
europepmc   +1 more source

Smuggling of the Dimethyltryptamine Drug in the Ayahuasca Drink

Drug control, 2019
openaire   +1 more source

Correction: Neural mechanisms of psychedelic visual imagery. [PDF]

Mol Psychiatry
Stoliker D, Preller KH, Novelli L, Anticevic A, Egan GF, Vollenweider FX, Razi A.   +6 more
europepmc   +1 more source

Continuous flow synthesis of N,N-dimethyltryptamine (DMT) analogues with therapeutic potential. [PDF]

RSC Med Chem
Simoens A, Dejaegere A, Vandevelde M, Stevens CV.   +3 more
europepmc   +1 more source

Dimethyltryptamine: endogenous role and therapeutic potential

, 2018
openaire   +2 more sources

Safety, Pharmacokinetics, and Pharmacodynamics of a 6-h N,N-Dimethyltryptamine (DMT) Infusion in Healthy Volunteers: A Randomized, Double-Blind, Placebo-Controlled Trial. [PDF]

Clin Transl Sci
van der Heijden KV, Zuiker RGJA, Otto ME, Bryan CS, Stewart N, Stillwell C, De Kam ML, van Leuken MB, van Gerven JMA, Jacobs GE.   +9 more
europepmc   +1 more source